Strategic Partnerships Institut Imagine actively collaborates with major European rare disease networks and funders (EURORDIS, ERDERA, AFM-Telethon) and partners like TEDDY Network, AP-HP, and SK pharmteco, indicating strong alliance potential for joint research, clinical trials, and funded programs.

translational research The institute sits at the nexus of basic science and clinical application with ultra-modern facilities and large patient cohorts, creating opportunities to offer contract research, translational studies, and access to curated patient data for biotech and pharma collaborators.

Clinical Trial Ready Established collaboration with clinical sponsors and capability to produce therapeutic vectors suggests potential for partner-sponsored gene therapy trials, vector production services, and regulatory-compliant translational development support.

Tech Enablement A diverse tech stack including Illumina, NoSQL, and data-driven platforms plus the RareSim digital education tool demonstrates capacity for genomics data services, analytics, and digital training collaborations with life sciences vendors.

Geographic & Market Fit Located in Paris within Necker Children’s Hospital with a sizeable workforce and focus on pediatric genetic diseases positions them as a gateway for EU market entry, local CRO partnerships, and access to European patient cohorts for multinational programs.